Showing results (121-130 of 247) with videos related to
Sort By:
Pageof 25
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 1999
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadineM Cvetkovic, B Leake, M F Fromm, et al.Biochemical and Biophysical Research Communications|July 7, 2009
Functionalized silicon quantum dots tailored for targeted siRNA deliveryS Klein, O Zolk, M F Fromm, et al.European Journal of Pain (London, England)|February 17, 2012
Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain reliefB Renner, G Walter, J Strauss, et al.Genesis (New York, N.Y. : 2000)|May 8, 2013
Proliferation of embryonic cardiomyocytes in zebrafish requires the sodium channel scn5LabJ S Bennett, D M Stroud, J R Becker, et al.Circulation|November 1, 1989
Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillationD M Roden, J T Lee, R L Woosley, et al.Angiology|February 1, 1987
Pharmacologic evaluation of standard and controlled-release disopyramideL A Siddoway, J T Barbey, D M Roden, et al.Clinical Pharmacology and Therapeutics|July 26, 2014
Inconsistencies and misleading information in officially approved prescribing information from three major drug marketsB Pfistermeister, A Saß, M Criegee-Rieck, et al.British Journal of Clinical Pharmacology|March 28, 1998
Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme inductionM F Fromm, K Dilger, D Busse, et al.Circulation|May 1, 1994
An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapyH K Kroemer, M F Fromm, K Bühl, et al.Pharmacogenetics|December 11, 1999
Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6K Dilger, B Greiner, M F Fromm, et al.Pageof 25